RxDoctor Payments Data

Amanda Stites

Family · Salem, MONPI 1508510298

Payments from drug & device makers

$1,247in general payments, 2019–2025

Across 74 payments — averaging $16.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$176
  • Lilly USA, LLC$165
  • GSK$146
  • Novo Nordisk$138
  • AbbVie$136
  • Amgen$87
  • plus $398 from 8 others

What the payments were for

  • Food & beverage$1,247100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,247 in reported general payments places this provider in the 70th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$7,551
Medicare patients
80
Services billed
119

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter54$36,899
OzempicSemaglutide33$36,267
MounjaroTirzepatide12$17,737
EliquisApixaban12$11,333
RybelsusSemaglutide11$9,972
LinzessLinaclotide12$7,572
Insulin Lispro Kwikpen U-100Insulin Lispro15$3,217
Gabapentin139$1,900
Buspirone Hcl82$1,485
Albuterol Sulfate HfaAlbuterol Sulfate76$1,444
Duloxetine Hcl48$1,171
Famotidine31$762
Nystatin45$701
Ventolin HfaAlbuterol Sulfate12$673
Omeprazole50$645

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$138$46,23944 claims
GSKTrelegy Ellipta$146$36,89954 claims
Lilly USA, LLCMounjaro$165$17,73712 claims
AbbVieLinzess$136$7,57212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,812 family providers in Missouri.

Other family in Salem

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →